Glycolysis is a central metabolic pathway by which cells obtain energy from sugar. Cancer cells in particular have long been ...

Coherus markets LOQTORZI® (toripalimab-tpzi), a novel next-generation PD-1 inhibitor, and UDENYCA® (pegfilgrastim-cbqv), a biosimilar of Neulasta. In December 2024, Coherus announced the planned ...

Nanobiotix begins patient dosing in new randomized phase 2 study of JNJ-1900 for patients with stage 3 unresectable NSCLC: Paris Wednesday, January 22, 2025, 13:00 Hrs [IST] Nanob ...

Artax Biopharma, Inc., a clinical-stage biotechnology company focused on transforming the treatment of autoimmune diseases, today announces achievement of clinical validation through its Phase 2a ...

New documents clarify how the FDA plans to regulate AI-enabled devices, experts say, but several important questions remain ...

Warnings of water and air contamination have locals on high alert. Some are taking safety into their own hands.

Arcus Biosciences, Inc. , a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with cancer, today announced that ...

Johnson & Johnson (NYSE:JNJ) reported its third-quarter 2024 earnings, surpassing analysts' expectations with an adjusted earnings per share (EPS) of $2.04, slightly above the forecasted $2.02. The ...